DOJ SEAL
U.S. DEPARTMENT of JUSTICE CONTACT US A-Z INDEX
About » Office Locations » Dallas Division » Dallas Division News
Dallas NEWS

Two Defendants Sentenced in Opioid Pill Mill Case

MAR 24 (DALLAS, Texas) - Ivery Myers, 64, and Cornelius Delshun Robinson, a/k/a “Tadow,” 37, both of Houston, Texas were sentenced by U.S. District Judge Sidney A. Fitzwater stemming from their involvement in a “pill mill” operation, announced U.S. Attorney John Parker of the Northern District of Texas.


Judge Fitzwater sentenced Myers to 37 months in federal prison following his guilty plea to one count of conspiracy to distribute a controlled substance in October 2015.  Robinson was sentenced to 120 months in federal prison following his guilty plea to the same offense in November 2015. Both defendants have been in custody since their arrest.
In March 2015, a federal grand jury in Dallas indicted 23 individuals, including Myers and Robinson, on offenses related to their participation in a prescription drug distribution conspiracy.  That indictment alleged that from at least May 2013 through July 2014, the defendants participated in a scheme to illicitly obtain prescriptions for pain medications, such as oxycodone and hydrocodone, and then distribute those controlled substances for profit.  As part of the conspiracy, individuals, often homeless or of limited means, were recruited and paid to pose as patients at medical clinics, including the McAllen Medical Clinic in Dallas, to obtain prescriptions to fill those prescriptions at designated pharmacies.
According to plea documents filed for Myers, on February 24, 2014, acting at the direction of Robinson, co-conspirator Shane Barron drove him to Brady, Texas, and then San Angelo, Texas, to obtain oxycodone with the intent to distribute it later.  Myers presented a prescription issued to another individual at a Walmart located in Brady, Texas, and obtained 120 30mg oxycodone pills.  After obtaining the oxycodone in Brady, Texas, he and Barron transferred the oxycodone from the prescription bottle labelled for the other individual into a prescription bottle labelled for Shane Barron and disposed of the original bottle. Barron then drove Myers to San Angelo, Texas, to fill another prescription for oxycodone.

According to documents filed for Robinson, on multiple occasions Robinson obtained oxycodone from sources in Dallas and Houston and distributed oxycodone to customers in Texas and Louisiana. Robinson recruited and paid individuals to pose as patients at medical clinics to obtain prescriptions for oxycodone. He paid the recruits to go to pharmacies to fill the prescriptions. He also paid for clinic visits and for the prescriptions. He sent co-conspirators, including Ivery Myers and Shane Barron, to fill prescriptions as far away as San Angelo and Abilene to minimize the possibility of detection by law enforcement. Robinson then obtained the oxycodone and distributed it for profit.  On May 25, 2013, in St. Martin's Parish, Louisiana, Robinson possessed approximately 1,543 oxycodone pills, consisting of 1,161 30mg oxycodone pills and 382 15mg oxycodone pills.  

This Organized Crime Drug Enforcement Task Force (OCDETF) was investigated by the Drug Enforcement Administration and the Internal Revenue Service Criminal Investigation, with assistance from the Texas Department of Public Safety, the Louisiana State Police, the Grand Prairie Police Department, the Dallas Police Department, the Houston Police Department, the Arlington Police Department, the Greenville Police Department, the Parker County Sheriff’s Office, the U.S. Marshal’s Service, the U.S. Postal Inspection Service, and the Diplomatic Security Service.  Assistant U.S. Attorney Mary Walters prosecuted.

STAY CONNECTED

Receive E-mail Updates Receive E-mail Updates @DEAHQ Twitter Account button Hover @DEAHQ Twitter Account button Report Synthetic Drug Source button Hover Report Synthetic Drug Source button


Stay Connected Facebook Twitter YouTube

 

A-Z Index  Accessibility   Contact Us  Environmental Stewardship   FOIA  Legal Policies & Disclaimers  
No FEAR Act   Privacy Policy Plug-Ins USA.gov Whistleblower Protection